Skip to main content
75°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Viking Therapeutics Inc
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Merck & Co Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Breaking News: Markets
Roche Holding AG
Business
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Science
Health care industry
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Pharmaceuticals
Business
Breaking News: Business
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Eli Lilly and Co
Mad Money
Novo Nordisk A/S
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Streaming media technology
Economic policy
Stock markets
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Asia Markets
Commercial banking
Technology
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
U/S/ Markets
Investing
Biotechnology
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Deutsche Bank AG
Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Gilead Sciences Inc
Healthy Returns
Altimmune Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Altimmune Inc
Healthy Returns
Gilead Sciences Inc
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Novo Nordisk A/S
Paramount Global
Investment strategy
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
China Economy
Biotech and Pharmaceuticals
Europe News
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Eli Lilly and Co
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Markets
Novo Nordisk A/S
Europe News
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Novo Nordisk A/S
Labor economy
Biotech and Pharmaceuticals
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
Prices
Ibex Ltd
World Markets
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Business
Weight management
Obesity
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Investment Strategy
Business
Tegna Inc
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Finance
NVIDIA Corp
Markets
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Technology
Mobile
Internet
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health care industry
Science
Eli Lilly and Co
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
Health & Science
Novo Nordisk A/S
Europe News
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.